| Toward minimal residual disease-directed therapy in melanoma F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ... Cell 174 (4), 843-855. e19, 2018 | 569 | 2018 |
| Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice IM Moya, SA Castaldo, L Van den Mooter, S Soheily, L Sansores-Garcia, ... Science 366 (6468), 1029-1034, 2019 | 154 | 2019 |
| RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway D Alonso-Curbelo, E Riveiro-Falkenbach, E Pérez-Guijarro, M Cifdaloz, ... Cancer cell 26 (1), 61-76, 2014 | 115 | 2014 |
| PHGDH heterogeneity potentiates cancer cell dissemination and metastasis M Rossi, P Altea-Manzano, M Demicco, G Doglioni, L Bornes, M Fukano, ... Nature 605 (7911), 747-753, 2022 | 93 | 2022 |
| Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma O Marin-Bejar, A Rogiers, M Dewaele, J Femel, P Karras, J Pozniak, ... Cancer Cell 39 (8), 1135-1149. e8, 2021 | 89 | 2021 |
| A cellular hierarchy in melanoma uncouples growth and metastasis P Karras, I Bordeu, J Pozniak, A Nowosad, C Pazzi, N Van Raemdonck, ... Nature 610 (7930), 190-198, 2022 | 85 | 2022 |
| Cross-species analysis of enhancer logic using deep learning L Minnoye, II Taskiran, D Mauduit, M Fazio, L Van Aerschot, ... Genome research 30 (12), 1815-1834, 2020 | 72 | 2020 |
| Epithelial‐to‐mesenchymal‐like transition events in melanoma D Pedri, P Karras, E Landeloos, JC Marine, F Rambow The FEBS journal 289 (5), 1352-1368, 2022 | 65 | 2022 |
| A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression II Verginadis, H Avgousti, J Monslow, G Skoufos, F Chinga, K Kim, ... Nature cell biology 24 (6), 940-953, 2022 | 58 | 2022 |
| p62/SQSTM1 fuels melanoma progression by opposing mRNA decay of a selective set of pro-metastatic factors P Karras, E Riveiro-Falkenbach, E Cañón, C Tejedo, TG Calvo, ... Cancer Cell 35 (1), 46-63. e10, 2019 | 57 | 2019 |
| Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers E Pérez-Guijarro, P Karras, M Cifdaloz, R Martínez-Herranz, E Cañón, ... Nature communications 7 (1), 13418, 2016 | 48 | 2016 |
| Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5 M García-Fernández, P Karras, A Checinska, E Cañón, GT Calvo, ... Autophagy 12 (10), 1776-1790, 2016 | 43 | 2016 |
| Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma R Vendramin, V Katopodi, S Cinque, A Konnova, Z Knezevic, S Adnane, ... Journal of Experimental Medicine 218 (9), e20210571, 2021 | 34 | 2021 |
| Disseminated melanoma cells transdifferentiate into endothelial cells in intravascular niches at metastatic sites X Li, P Karras, R Torres, F Rambow, J van den Oord, JC Marine, L Kos Cell Reports 31 (11), 2020 | 30 | 2020 |
| Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1 M Cifdaloz, L Osterloh, O Graña, E Riveiro-Falkenbach, ... Nature communications 8 (1), 2249, 2017 | 27 | 2017 |
| RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development D Alonso-Curbelo, L Osterloh, E Canon, TG Calvo, R Martinez-Herranz, ... Oncotarget 6 (14), 11848, 2015 | 27 | 2015 |
| Vascular endothelial-cadherin downregulation as a feature of endothelial transdifferentiation in monocrotaline-induced pulmonary hypertension I Nikitopoulou, SE Orfanos, A Kotanidou, V Maltabe, N Manitsopoulos, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 311 (2 …, 2016 | 26 | 2016 |
| Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers ISC Verploegh, A Conidi, RWW Brouwer, HE Balcioglu, P Karras, ... Neuro-oncology 24 (12), 2133-2145, 2022 | 12 | 2022 |
| A TCF4/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanoma J Pozniak, D Pedri, E Landeloos, YV Herck, A Antoranz, P Karras, ... bioRxiv, 2022.08. 11.502598, 2022 | 11 | 2022 |
| A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma J Pozniak, D Pedri, E Landeloos, Y Van Herck, A Antoranz, ... Cell 187 (1), 166-183. e25, 2024 | 8 | 2024 |
